Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Autism Spectrum Disorder

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychopharmacology of Eugeroics-<i>The Whole Nine Yards!</i>

Psychopharmacology bulletin·2026

Same author

Cariprazine for Autism-<i>A Case Report</i>.

Psychopharmacology bulletin·2026

Same author

Take "Oedipus" Off.

The primary care companion for CNS disorders·2026

Same author

Compulsive Polydipsia-Related Symptomatic Hyponatremia in a Low-Functioning Autistic Boy.

The primary care companion for CNS disorders·2026

Same author

Psychopharmacotherapy Updates.

The primary care companion for CNS disorders·2026

Same author

Clozapine in Child and Adolescent Psychiatry.

Paediatric drugs·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2025

Pentylenetetrazole-Induced Kindling Mouse Model

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Valproate-Autism Labyrinth.

Ahmed Naguy¹, Maryam Alqabandi²

¹Naguy, MBBch, MSc, MRCPsych (UK), Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, State of Kuwait.

Psychopharmacology Bulletin

|September 12, 2024

Summary

Valproate is an environmental risk factor for autism and a model for its study. Its complex actions may help address core autism symptoms beyond just controlling aggression.

Keywords:

autism folic acid irritability risk translational model valproate

More Related Videos

Strategies for Assessing Autistic-Like Behaviors in Mice

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Jun 13, 2025

Pentylenetetrazole-Induced Kindling Mouse Model

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Strategies for Assessing Autistic-Like Behaviors in Mice

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

Area of Science:

Neuroscience
Developmental Biology
Pharmacology

Background:

Valproate is a known environmental risk factor for autism spectrum disorder (ASD).
Valproate exposure in animal models has been used to study ASD.
The multifaceted mechanisms of valproate are not fully understood in the context of ASD.

Purpose of the Study:

To explore the complex mechanisms of valproate in relation to autism.
To investigate valproate's potential to address core autistic domains.
To move beyond valproate's known effects on aggressive behaviors in ASD models.

Main Methods:

Review of existing literature on valproate and autism.
Analysis of preclinical studies using valproate as an autism model.
Pharmacological and neurobiological assessments of valproate's effects.

Main Results:

Valproate's role as an environmental risk factor is well-established.
Valproate serves as a valuable translational model for autism research.
Emerging evidence suggests valproate's potential impact on core autism-related behaviors.

Conclusions:

Valproate's complex pharmacology offers insights into autism's underlying mechanisms.
Further research into valproate's mode of action may reveal novel therapeutic targets for core autism symptoms.
Valproate's utility extends beyond behavioral control, potentially addressing broader autistic domains.